Bespoke Extracts, Inc. (OTCPK: BSPK)
Health Care · Pharmaceuticals · US
$0.00
+28.57% today · -99.5% 1Y
Bespoke Extracts, Inc. (OTCPK: BSPK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.13K and employs 2 people.
Over the last twelve months the share price has lost 99.5%, trading between 0.00 and 0.35.
Tweenvest scores Bespoke Extracts, Inc. across four factors: quality 15/100, value 58/100, growth 100/100. Its strongest factor is growth.
BSPK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.13K
- Revenue (TTM)
- $1.42M
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- $0.35
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.25M
- Employees
- 2
- Next earnings
- —
About Bespoke Extracts, Inc.
Bespoke Extracts, Inc. offers a range of cannabidiol (CBD) products sourced from hemp. Their diverse inventory includes various CBD formulations, such as those infused with manuka honey, as well as lotions and balms. Additionally, the company provides CBD extracts available in capsule form, topical applications, and edible gummies. These items are sold directly to consumers through their dedicated e-commerce website, bespokeextracts.com. The business, which changed its name from DiMi Telematics International, Inc. to Bespoke Extracts, Inc. in March 2017, is headquartered in Denver, Colorado.
- ISIN
- US08634Q2084
- Founded
- 1988
- Listed since
- Feb 4, 2008
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.